An investigation of toxicity potential of nimesulide in juvenile rats;Juvenil sıçanlarda nimesulid'in toksisite potansiyelinin araştırılması

Turkish Journal of Pharmaceutical Sciences

Volumn 8, Issue 2, 2011, Pages 147-158

  Sozer, Sumru ^a   Ortac, Ragip ^b   Lermioglu, Ferzan ^a  

^a EGE UNIVERSITY   (Turkey)

^b Behcet Uz Children's Hospital   (Turkey)

Author keywords

Antioxidant enzymes; Juvenile; Nimesulide; Oxidative stress

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; NIMESULIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; TISSUE INJURY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 79960150917     PISSN: 1304530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Davis, R., Brogden, R.N., "Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy" Drugs, 48, 431-454, 1994.
2. Rabasseda, X., "Nimesulide: a selective cyclooxygenase 2 inhibitor antiinflammatory drugs" Drugs Today, 32, 1-23, 1996.
3. Famaey, JP., "In vitro and in vivo pharmacological evidence of selective cyclooxygense-2 inhibition by nimesulide: an overview" Inflamation Res., 46, 437-446, 1997.
4. Principi, N., "Guidelines for the therapeutic use of NSAIDs in pediatrics" Minerva Pediatr., 49(9), 379-386, 1997.
5. Das, B., Sarkar, C., Majumder, A.G., "Medication use for pediatric upper respiratory tract infections" Fundamental Clin. Pharmacol., 20(4), 385-390, 2006.
6. Leone, R., Sottosanti, L., Luisa Iorio, M., Santuccio, C., Conforti, A., Sabatini, V., Moretti, U., Venegoni, M., "Drug-related deaths: An analysis of the Italian spontaneous reporting database" Drug Safety, 31(8), 703-713, 2008.
7. Balasubramaniam, J., "Nimesulide and neonatal renal failure" Lancet, Feb, 355(9203), 575, 2000.
8. Schattner, A., Sokolovskaya, N., Cohen, J., "Fatal hepatitis and renal failure during treatment with nimesulide" J. Int. Med., 247(1), 153-155, 2000.
9. Thawani, V., Sontakke, S., Gharpure, K., Pimpalkhute, S., "Nimesulide: The current controversy" Indian J. Pharmacol., 35, 121-122, 2003.
10. Van Steenbergen, W., Peeters, P., De Bondt, J., Staessen, D., Buscher, H., Laporta, T., Roskams, T., Desmet, V., "Nimesulide-induced acute hepatitis: evidence from six cases" J. Hepatology, 29(1), 135-141, 1998.
11. Tan, H.H., Ong, W.M.C., Lai, S.H., Chow, W.C., "Nimesulide-induced hepatotoxicity and fatal hepatic failure" Singapore Medical J., 48(6), 582-585, 2007.
12. Gupta, P., Sachdev, H.P., "Safety of oral use of nimesulide in children: systematic review of randomized controlled trials" Indian Pediatrics, 40(6), 518-531, 2003.
13. Bissoli, F., "Comment on: Severe hemolytic anemia and fatal hepatic failure associated with nimesulide" Digestive Liver Disease, 41, 450-452, 2009.
14. Sheu, S.S., Nauduri, D., Anders, M.W., "Targeting antioxidants to mitochondria: a new therapeutic direction" Biochimica et Biophysica Acta, 1762(2), 256-265, 2006.
15. Tripathi, M., Singh, B.K., Mishra, C., Raisuddin, S., Kakkar, P., "Involvement of mitochondria mediated pathways in hepatoprotection conferred by Fumaria parviflora Lam. extract against nimesulide induced apoptosis in vitro" Toxicology In Vitro, 24(2), 495-508, 2010.
16. Boelsterli, U.A., Ho, H.K., Zhou, S., Leow, K.Y., "Bioactivation and hepatotoxicity of nitroaromatic drugs" Current Drug Metabolism, 7(7), 715-727, 2006.
17. Rainsford, K.D., "Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide" Inflammopharmacology, 14, 120-137, 2006.
18. Facino, R.M., Carini, M., Aldini, G., "Antioxidant activity of nimesulide and its main metabolites" Drugs, 46(Suppl.1), 15-21, 1993.
19. Facino, R.M., Carini, M., Aldini, G., Saibene, L., Macciocchi, A., "Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model" Int. J. Tissue Reac., 15, 225-234, 1993.
20. Facino, R.M., Carini, M., Aldini, G., Saibene, L., Morelli, R., "Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulide" Arzneimittelforschung, 45(10), 1102-1109, 1995.
21. Sheth N., "Essentials for starting a pediatric clinical study (4): Clinical pediatric safety planning based on preclinical toxicity studies and pediatric pharmacovigilance guidance" J. Toxicol. Sci., 34 Suppl 2:SP 327-329, 2009.
22. Satoh, K., "Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method" Clin. Chim. Acta, 90, 37-43, 1978.
23. Yagi, K., "Assay for blood plasma or serum" Methods in Enzymology, 105, 328-331, 1984.
24. Aebi, H., "Catalase in vitro" Methods in Enzymology, 105, 121-126, 1984.
25. Misra, H.P., Fridovich, I., "The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase" J. Biol. Chem., 25, 247(10), 3170-3175, 1972.
26. Pleban, P.A., Munyani, A., Beachum, J., "Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes" Clin. Chem., 28(2), 311-316, 1982.
27. Tietz, N.W., Biochemical Aspects of Hematology. In: Fundamentals of Clinical Chemistry, 3th ed. p.803-804, Philadelphia PA.: W.B. Saunders; 1987.
28. Lecomte, J., Monti, T., Pochobradsky, M.G., "Antipyretic effects of nimesulide in paediatric practice: a double-blind study" Current Medical Research and Opinion, 12(5), 296-303, 1991.
29. Facchini, R., Selva, G., Peretti, G., "Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fractures" Drugs, 46(Suppl 1), 238-241, 1993.
30. Ugazio, A.G., Guarnaccia, S., Berardi, M., Renzetti, I., "Clinical and pharmacokinetic study of nimesulide in children" Drugs, 46(Suppl 1), 215-218, 1993.
31. Harish, J., Chowdhary, S.K., Narasimhan, K.L., Mahajan, J.K., Rao, K.L., "Efficacy of nimesulide in pain relief after day care surgery" Indian Pediatrics, Feb, 39(2), 178-182, 2002.
32. Bernareggi, A., "Clinical pharmacokinetics of nimesulide" Clinical Pharmacokinetics, 35(4), 247-74,1998.
33. Wallace, J.L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K.A., MacNaughton WK., "Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity" Gastroenterology, 115(1), 101-109, 1998.
34. Toutain, P.L., Cester, C.C., Haak, T., Laroute, V., "A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog" J. Vet. Pharmacol. Ther., 24(1), 43-55, 2001.
35. Kopff, M., Kopff, A., Kowalczyk, E., "The effect of nonsteroidal anti-inflammatory drugs on oxidative/antioxidative balance" Polsky Merkuriusz Lekarski, 23(135), 184-187, 2007.
36. Wang, Y., Deng, X.L., Xiao, X.H., Yuan, B.X., "A non-steroidal anti-inflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases" Current Neurovascular Res., 4(3), 176-183, 2007.
37. Nair, P., Kanwar, S.S., Sanyal, S.N., "Effects of nonsteroidal anti-inflammatory drugs on the antioxidant defense system and the membrane functions in the rat intestine" Nutricion Hospitalaria, 21(6), 638-649, 2006.
38. Chakraborty, S., Kar, S.K., Roy, K., Sengupta, C., "Exploring effects of different nonsteroidal antiinflammatory drugs on malondialdehyde profile" Acta Poloniae Pharmaceutica, 63(2), 83-88, 2006.
39. Demircan, B., Celik, G., Suleyman, H., Akcay, F., "Effects of indomethacin, celecoxib and meloxicam on glutathione, malondialdehyde and myeloperoxidase in rat gastric tissue" The Pain Clinics, 4, 383-388, 2005.
40. Sozer, S., Karadagli{dotless}, F., Ortac, R., Lermioglu, F., "Investigation of hepatotoxic effect of nimesulide on rats" Ege J. Med., 47(1), 1-5, 2008.
41. Mates, J.M., Perez-Gomez, C., Nunez de Castro, I., "Antioxidant enzymes and human diseases" Clin. Biochem., 32(8), 595-603, 1999.
42. Al Suleimani, Y.M., Abdelrahman, A.M., AlMahruqi, A.S., Alhseini, I.S., Tageldin, M.H., Mansour, M.E., Ali, B.H., "Interaction of nimesulide, a cyclooxygenase-2 inhibitor, with cisplatin in normotensive and spontaneously hypertensive rats" Food Chem. Toxicol., 48(1), 139-144, 2010.
43. Prevot, A., Mosig, D., Martini, S., Guignard, J.P., "Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit" Pediatric Res., 55(2), 254-260, 2004.
44. Strazzullo, P., Puig, J.G., "Uric acid and oxidative stress: relative impact on cardiovascular risk" Nutrition, Metabolism and Cardiovascular Disease, 17, 409-414, 2007.
45. Demartini, F.E., "Hyperuricemia induced by drugs" Arthritis and Rheumatism, 8(5), 823-829, 1965.
46. Kowalczyk, E., Kopff, A., Błaszczyk, J., Fijałkowski, P., Kopff, M., "The influence of selected nonsteroidal anti-inflammatory drugs on antioxidative enzymes activity" Polskie Archiwum Medycyny Wewnetrznej, 115(2), 112-117, 2006.
47. Bjarnason, I., Bissoli, F., Conforti, A., Adverse reactions and their mechanisms from nimesulide. In: Nimesulide. Actions and Uses. Ed(s). Rainsford KD, p.315-415 Basel: Birkhäuser; 2005.
48. Rodrigo, L., de Francisco, R., Pérez-Pariente, J.M., Cadahia, V., Tojo, R., Rodriguez, M., Lucena, M.I., Andrade, R.J., "Nimesulide-induced severe hemolytic anemia and acute liver failure leading to liver transplantation" Scand. J. Gastroenterol., 37(11), 1341-1343, 2002.
49. Chatterjee, S., Sarkar, K., Sil, P.C., "Herbal (Phyllanthus niruri) protein isolate protects liver from nimesulide induced oxidative stres" Pathophysiology, 13(2), 95-102, 2006.
50. Sohi, K.K., Khanduja, K.L., "Nimesulide affects antioxidant status during acute lung inflammation in rats" Indian J. Biochem. Biophysics, 40, 238-245, 2003.
51. Orhan, H., Doǧruer, D.S., Çaki{dotless}r, B., Sahin, G., Şahin, M.F., "The in vitro effects of new non-steroidal antiinflammatory compounds on antioxidant system of human erythrocytes" Experimental and Toxicologic Pathology, 51(4-5), 397-402, 1999.
52. Kothapalli, D., Fuki, I., Ali, K., Stewart, S.A., Zhao, L., Yahil, R., Kwiatkowski, D., Hawthorne, E.A., FitzGerald, G.A., Phillips, M.C., Lund-Katz, S., Puré, E., Rader, D.J., Assoian, R.K., "Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation" J Clin. Invest, 113(4), 609-618, 2004.